A carregar...
Development and characterization of liposomal formulation of bortezomib
Bortezomib is a proteasome inhibitor used for the treatment of multiple myeloma. The poor pharmacokinetic profile and off-target adverse effects provide a strong incentive to develop drug delivery systems for bortezomib. In the past, liposomal encapsulation has been proven to improve the therapeutic...
Na minha lista:
| Publicado no: | Int J Pharm X |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6733293/ https://ncbi.nlm.nih.gov/pubmed/31517276 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijpx.2019.100011 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|